Researchers find transport molecule has unexpected role

June 14, 2018 by Deborah Wormser, UT Southwestern Medical Center
UT Southwestern researchers recently reported a basic science finding that might someday lead to better treatments for neurodegenerative diseases like a hereditary form of Lou Gehrig's disease. Credit: UT Southwestern

UT Southwestern researchers recently reported a basic science finding that might someday lead to better treatments for neurodegenerative diseases like a hereditary form of Lou Gehrig's disease.

In a study published in the journal Cell, Dr. Yuh Min Chook, Professor of Pharmacology and Biophysics, and Dr. Michael Rosen, Chair of Biophysics and an Investigator in the Howard Hughes Medical Institute (HHMI), are corresponding authors of the work in the emerging field of biological . This field encompasses aspects of the organization of the cell interior, including how proteins can phase separate like oil does from water. Dr. Chook, a Eugene McDermott Scholar in Medical Research, holds the Alfred and Mabel Gilman Chair in Molecular Pharmacology. Dr. Rosen, holds the Mar Nell and F. Andrew Bell Distinguished Chair in Biochemistry.

Their work identifies details in how molecules bind—or fail to bind—to each other for transport into the nucleus of nerve cells in the brain and spinal cord. Proper binding and transport appear essential for the protein named FUS (fused in sarcoma).

Normally, FUS binds to one of a class of nuclear transport receptors, in this case the importin molecule called karyopherin-β2 (Kapβ2), which transports proteins into the nucleus. Proper binding of FUS to Kapβ2 is necessary to take FUS into the nucleus, ensuring its correct cellular function. FUS that cannot be transported into the nucleus remains in the soupy cytoplasm of the cell and tends to self-associate (stick to itself) and form droplets of FUS suspended in cytoplasm that look like the droplets that form when a flask of oil and vinegar dressing is shaken.

Mutations in this transport system cause a genetic neurodegenerative disease called familial amyotrophic lateral sclerosis (fALS), also known as hereditary Lou Gehrig's disease.

The National Institutes of Health (NIH) describes ALS as a progressive disease that kills nerve cells controlling muscle movement. Death usually occurs within 10 years after symptom onset. An estimated 90 to 95 percent of ALS cases occur sporadically in people with no apparent family history. Several genes have been identified that, when deficient, underlie the familial form of the disease, which accounts for an estimated 5 to 10 percent of all ALS cases, according to the NIH.

In 2006, Dr. Chook identified a family of nuclear localization signals, dubbed the PY-NLS, used by the FUS protein. A PY-NLS sits at one end of the elongated FUS molecule and acts like a ZIP code for delivery of the FUS protein to the cell's nucleus. The NLS she identified became recognized as central to the development of fALS in which the FUS protein cargo cannot properly enter the nucleus and instead aggregates in the cell's cytoplasm surrounding the nucleus.

In 2012, Dr. Chook showed how the importin Kapβ2 recognizes the PY-NLS on the FUS protein and delivers it to the nucleus when the system is working properly. When the transport system fails, droplets of the FUS protein pile up in the cytoplasm, perhaps eventually becoming solid and toxic within the motor neurons of ALS patients.

Her discoveries allowed neuroscientists to figure out how FUS mutations lead to the aggregation of the FUS protein in the cytoplasm, but many questions remain unanswered. "The mutant FUS forms little liquid droplets within 10 minutes and these become less liquid and more solid over time, forming fibrils if the sample is left for 24 hours," Dr. Chook said.

"My laboratory has been working on phase separation, and Yuh Min's laboratory has done all this work on the FUS protein transport system. We wondered if the FUS droplets that we and others had observed would be affected by importin binding," Dr. Rosen said.

In studies of the purified FUS and Kapβ2 proteins, they found that the Kapβ2 blocks phase separation of FUS and that the importin's ability to block phase separation depends on its ability to read the ZIP code of the PY-NLS nuclear localization signal. When the ZIP code is unreadable, as in mutated FUS, phase separation into droplets continues unimpeded, the researchers said.

"If you add a small amount of Kapβ2 protein to FUS proteins that have formed into droplets, within five minutes the droplets disappear. So the importin Kapβ2 is playing two roles: It is the transporter but also protects the FUS protein against phase separation and aggregation," Dr. Chook said.

Using nuclear magnetic resonance (NMR) spectroscopy technology available in the Biophysics Department, the researchers next studied exactly how the Kapβ2 importin binds to the FUS protein. They found that under normal conditions, the Kapβ2 and FUS proteins bind very strongly to each other because of interactions at the nuclear localization signal—the ZIP code-like PY-NLS that sits at one end of the long FUS protein molecule. They also found that strong binding at the PY-NLS enables weaker and very brief interactions between other parts of the importin molecule and many other regions of the FUS protein.

"The NMR equipment is highly sensitive to time intervals, making it possible to 'see' the transient binding of the two molecules. Doing so would be impossible with a static system such as X-ray crystallography," Dr. Rosen explained.

"Binding at the right time, in the right place, in the right way is really important. All this transient binding appears to keep the FUS from interacting with itself and inhibits assembly into droplets," Dr. Chook said. "Those droplets are probably the initial stages of the aggregates that are a hallmark of familial ALS. If we could find a way to keep the from forming, perhaps we could change the course of that neurodegenerative disease."

Explore further: Researchers describe mechanism of protein accumulation in neurodegenerative diseases

More information: Takuya Yoshizawa et al. Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites, Cell (2018). DOI: 10.1016/j.cell.2018.03.003

Related Stories

Researchers describe mechanism of protein accumulation in neurodegenerative diseases

April 20, 2018
Ludwig-Maximilians-Universitaet (LMU) in Munich researchers have characterized the mechanism that initiates the pathological aggregation of the protein FUS, which plays a central role in two distinct neurodegenerative diseases.

Putting proteins in their proper place

April 19, 2018
A host of special molecules called nuclear RNA-binding proteins (RBPs), when misplaced outside the nucleus, form the harmful clumps seen in several brain disorders, including frontotemporal dementia (FTD) and amyotrophic ...

How shuttling proteins operate nuclear pores

September 4, 2017
Nuclear pore complexes are tiny channels where the exchange of substances between the cell nucleus and the cytoplasm takes place. Scientists at the University of Basel report on startling new research that might overturn ...

Researchers identify 'Achilles' heel' of PTEN that helps drive prostate cancer progression

February 13, 2017
Researchers at Cold Spring Harbor Laboratory (CSHL) have discovered that a protein called Importin-11 protects the anti-cancer protein PTEN from destruction by transporting it into the cell nucleus. A study they publish today ...

Researchers close to understanding 'disease mechanisms' of ALS

March 8, 2018
Syracuse University researchers are making strides in understanding the disease mechanism of amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease.

A newly identified complex of Tau and RNA suggests a path to aggregation

July 6, 2017
The hallmark of many neurodegenerative diseases is the formation of protein aggregates, yet how and why these aggregates form remains a mystery. In a study publishing 6 July in the open access journal PLOS Biology by the ...

Recommended for you

How does brain structure influence performance on language tasks?

October 17, 2018
The architecture of each person's brain is unique, and differences may influence how quickly people can complete various cognitive tasks.

Regulating microglial activity may reduce inflammation in neurodegenerative diseases

October 17, 2018
A group of Massachusetts General Hospital (MGH) investigators is proposing that targeting immune checkpoints—molecules that regulate the activity of the immune system—in immune cells called microglia could reduce the ...

New imaging tool captures how sound moves through the chinchilla ear

October 17, 2018
Researchers have developed a new device that can be used to visualize how sound-induced vibrations travel through the ear. The technology is providing new insight into how the ear receives and processes sound waves and, with ...

Sensory perception is not a one-way street

October 17, 2018
When we interact with the world, such as when we reach out to touch an object, the brain actively changes incoming sensory signals based on anticipation. This so-called 'sensory gating' has now been investigated by neuroscientists ...

Environmental factors may trigger onset of multiple sclerosis

October 16, 2018
A new Tel Aviv University study finds that certain environmental conditions may precipitate structural changes that take place in myelin sheaths in the onset of multiple sclerosis (MS). Myelin sheaths are the "insulating ...

Cesarean-born mice show altered patterns of brain development, study finds

October 15, 2018
Cesarean-born mice show altered patterns of cell death across the brain, exhibiting greater nerve cell death than vaginally delivered mice in at least one brain area, a finding by Georgia State University researchers that ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.